LANSDOWNE PARTNERS (UK) LLP - Q2 2020 holdings

$2.39 Billion is the total value of LANSDOWNE PARTNERS (UK) LLP's 120 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 34.8% .

 Value Shares↓ Weighting
DAL SellDELTA AIR LINES INC DEL$242,448,000
-17.4%
8,643,792
-16.0%
10.13%
-37.7%
AMAT SellAPPLIED MATLS INC$216,531,000
+4.2%
3,582,105
-21.0%
9.05%
-21.4%
LRCX SellLAM RESEARCH CORP$206,042,000
-4.8%
637,057
-29.3%
8.61%
-28.2%
ADI SellANALOG DEVICES INC$119,208,000
-12.7%
972,007
-36.2%
4.98%
-34.1%
TSM SellTAIWAN SEMICONDUCTOR MFG LTDsponsored adr$79,101,000
-8.5%
1,393,386
-22.9%
3.31%
-31.0%
UAL SellUNITED AIRLINES HLDGS INC$63,728,000
-55.8%
1,841,346
-59.7%
2.66%
-66.6%
ETN SellEATON CORP PLC$54,029,000
-36.5%
617,612
-43.6%
2.26%
-52.1%
NSC SellNORFOLK SOUTHERN CORP$52,994,000
+5.1%
301,844
-12.6%
2.22%
-20.8%
EGO SellELDORADO GOLD CORP NEW$43,036,000
+47.6%
4,436,723
-6.1%
1.80%
+11.3%
FSLR SellFIRST SOLAR INC$26,657,000
-64.7%
538,524
-74.3%
1.11%
-73.3%
DAR SellDARLING INGREDIENTS INC$17,952,000
+15.3%
729,140
-10.2%
0.75%
-13.1%
REGI SellRENEWABLE ENERGY GROUP INC$10,116,000
-61.9%
408,270
-68.5%
0.42%
-71.3%
GE SellGENERAL ELECTRIC CO$7,985,000
-83.9%
1,169,116
-81.3%
0.33%
-87.8%
SMMT SellSUMMIT THERAPEUTICS PLCspons ads$7,922,000
-21.0%
2,667,350
-36.9%
0.33%
-40.4%
NKE SellNIKE INCcl b$1,105,000
-27.5%
11,274
-38.8%
0.05%
-45.2%
BABA ExitALIBABA GROUP HLDG LTDsponsored ads$0-3,500
-100.0%
-0.04%
IQ ExitIQIYI INCsponsored ads$0-50,000
-100.0%
-0.05%
TT ExitTRANE TECHNOLOGIES PLC$0-31,246
-100.0%
-0.14%
AGI ExitALAMOS GOLD INC NEW$0-1,099,326
-100.0%
-0.30%
VTIQ ExitVECTOIQ ACQUISITION CORP$0-813,263
-100.0%
-0.48%
DHT ExitDHT HOLDINGS INC$0-1,307,082
-100.0%
-0.56%
UTX ExitUNITED TECHNOLOGIES CORP$0-702,120
-100.0%
-3.67%
TSLA ExitTESLA INCput$0-160,000
-100.0%
-4.65%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DELTA AIR LINES INC DEL38Q3 202325.1%
EATON CORP PLC33Q3 202311.6%
TAIWAN SEMICONDUCTOR MFG LTD25Q3 202317.9%
MANCHESTER UTD PLC NEW22Q3 20191.0%
SUMMIT THERAPEUTICS PLC22Q2 20200.6%
AMAZON COM INC21Q3 202313.9%
JPMORGAN CHASE & CO20Q1 201919.9%
CITIGROUP INC20Q4 202012.2%
FIRST SOLAR INC20Q3 20214.2%
UNITED TECHNOLOGIES CORP20Q1 20203.7%

View LANSDOWNE PARTNERS (UK) LLP's complete holdings history.

Latest significant ownerships (13-D/G)
LANSDOWNE PARTNERS (UK) LLP Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Supernova Partners Acquisition Co II, Ltd.February 14, 20222,152,9116.2%
Summit Therapeutics plcJune 17, 202013,664,8804.1%
Manchester United plcSold outFebruary 14, 202000.0%
CYTOKINETICS INCJanuary 30, 20182,647,9814.9%
RESPONSE GENETICS INCSold outFebruary 12, 201600.0%

View LANSDOWNE PARTNERS (UK) LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-14
SC 13G2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-10
SC 13G2023-02-08
13F-HR2022-11-10
13F-HR2022-08-12

View LANSDOWNE PARTNERS (UK) LLP's complete filings history.

Compare quarters

Export LANSDOWNE PARTNERS (UK) LLP's holdings